A Prospective, Single-Arm Multi-Center Study of the HARMONIC® 1100 Shears in Select Devices
Launched by ETHICON ENDO-SURGERY · Aug 31, 2021
Trial Information
Current as of July 23, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Pediatric population:
- • 1. Non-emergent procedure (general) where at least one vessel is planned to be transected by the HARMONIC 1100 Shears per the IFU;
- • 2. Less than 18 years of age at the time of procedure; and
- • 3. The subject's parent/legal guardian must be willing to give permission for the subject to participate in the study and provide written informed consent for the subject. In addition, assent must be obtained from pediatric subjects who possess the intellectual and emotional ability to comprehend the concepts involved in the study. If the pediatric subject is not able to provide assent (due to age, maturity and/or inability to intellectually and/or emotionally comprehend the study), the parent/legal guardian's written informed consent for the subject will be acceptable for the subject to be included in the study.
- Adult population:
- • 1. Elective procedure (general, gynecological, urological, or thoracic) where at least one vessel is planned to be transected by the HARMONIC 1100 Shears per the IFU;
- • 2. Willingness to give consent and comply with all study-related evaluations and visit schedule; and
- • 3. At least 18 years of age.
- Exclusion Criteria:
- • Preoperative
- • 1. Physical or psychological condition which would impair study participation;
- • 2. Female subjects, of childbearing age, who are pregnant; or
- • 3. Enrollment in a concurrent interventional clinical study that could impact the study endpoints.
- • Intraoperative
- • 1. The HARMONIC 1100 Shears were not attempted to be used for at least one single vessel transection during the surgical procedure.
About Ethicon Endo Surgery
Ethicon Endo-Surgery, a subsidiary of Johnson & Johnson, is a leading global innovator in surgical devices and technologies, specializing in minimally invasive surgical solutions. With a commitment to advancing patient care, the company focuses on developing cutting-edge products that enhance surgical efficiency and improve patient outcomes. Ethicon Endo-Surgery conducts rigorous clinical trials to evaluate the safety and efficacy of its innovative devices, contributing to the evolution of surgical practices across various specialties. Through collaboration with healthcare professionals and ongoing research, the company aims to set new standards in surgical performance and patient safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Indianapolis, Indiana, United States
Toronto, , Canada
Indianapolis, Indiana, United States
Edinburgh, Scotland, United Kingdom
Jacksonville, Florida, United States
Indianapolis, Indiana, United States
Montreal, , Canada
Patients applied
Trial Officials
Ethicon Endo-Surgery Clinical Trial
Study Director
Ethicon Endo-Surgery
Troy Markel, MD
Principal Investigator
Riley Hospital for Children at Indiana University Health
Attila Nakeeb, MD
Principal Investigator
IU Health University Hospital
Moishe Liberman, MD
Principal Investigator
Centre Hospitalier de l'Universite de Montreal
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials